Sansure Biotech Past Earnings Performance
Past criteria checks 0/6
Sansure Biotech's earnings have been declining at an average annual rate of -16.3%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been declining at an average rate of 3.1% per year. Sansure Biotech's return on equity is 2.9%, and it has net margins of 18.4%.
Key information
-16.3%
Earnings growth rate
-16.7%
EPS growth rate
Medical Equipment Industry Growth | 16.0% |
Revenue growth rate | -3.1% |
Return on equity | 2.9% |
Net Margin | 18.4% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit
Nov 03Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems
May 03Recent updates
Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit
Nov 03Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings
Oct 09Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital
Oct 03Is Sansure Biotech (SHSE:688289) A Risky Investment?
Sep 12Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected
Aug 21Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital
Jun 03Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems
May 03Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't
Apr 26Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher
Feb 28Revenue & Expenses Breakdown
How Sansure Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 1,407 | 259 | 733 | 247 |
30 Jun 24 | 1,296 | 429 | 676 | 222 |
31 Mar 24 | 1,203 | 385 | 642 | 204 |
31 Dec 23 | 1,007 | 364 | 552 | 195 |
30 Sep 23 | 3,015 | 638 | 868 | 289 |
30 Jun 23 | 4,188 | 904 | 930 | 321 |
31 Mar 23 | 5,206 | 1,345 | 949 | 334 |
31 Dec 22 | 6,450 | 1,937 | 985 | 331 |
30 Sep 22 | 5,316 | 2,084 | 599 | 276 |
30 Jun 22 | 5,176 | 2,247 | 568 | 235 |
31 Mar 22 | 4,791 | 2,272 | 499 | 208 |
31 Dec 21 | 4,515 | 2,243 | 507 | 187 |
30 Sep 21 | 4,425 | 2,361 | 464 | 111 |
30 Jun 21 | 4,691 | 2,506 | 566 | 106 |
31 Mar 21 | 5,526 | 3,046 | 672 | 95 |
31 Dec 20 | 4,763 | 2,617 | 627 | 83 |
30 Sep 20 | 3,727 | 2,034 | 575 | 76 |
30 Jun 20 | 2,299 | 1,263 | 355 | 50 |
31 Mar 20 | 683 | 233 | 211 | 40 |
31 Dec 19 | 365 | 39 | 161 | 39 |
31 Dec 18 | 303 | 7 | 134 | 35 |
31 Dec 17 | 225 | -11 | 105 | 28 |
Quality Earnings: 688289 has a large one-off gain of CN¥114.7M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 688289's current net profit margins (18.4%) are lower than last year (21.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688289's earnings have declined by 16.3% per year over the past 5 years.
Accelerating Growth: 688289's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688289 had negative earnings growth (-59.3%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Return on Equity
High ROE: 688289's Return on Equity (2.9%) is considered low.